Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye.
Indian J Ophthalmol
;
2007 Nov-Dec; 55(6): 460-2
Article
in English
| IMSEAR
| ID: sea-72221
ABSTRACT
Intracameral injection of bevacizumab (Avastin) helped in the successful regression of an anterior chamber neovascular membrane in a painful blind eye. The effect was persistent even after six months of follow-up. This is the first report on intracameral administration of bevacizumab with six months of follow-up.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Pain
/
Time Factors
/
Female
/
Humans
/
Blindness
/
Follow-Up Studies
/
Adult
/
Angiogenesis Inhibitors
/
Vascular Endothelial Growth Factor A
/
Injections
Type of study:
Observational study
/
Prognostic study
Language:
English
Journal:
Indian J Ophthalmol
Year:
2007
Type:
Article
Similar
MEDLINE
...
LILACS
LIS